Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glowee is a private environmental biotechnology company and brand focused on bioluminescent lighting rather than human therapeutics. Its technology uses non-pathogenic marine bacteria to generate light without external electricity, positioning the company at the intersection of biomimicry, synthetic biology, design, and sustainable urban infrastructure. The company markets bioluminescent installations and urban-lighting concepts for events, public spaces, and wellness-oriented experiential design. Glowee is not primarily a life sciences or healthcare company, although it applies biotechnology as an enabling technology. Public materials indicate the current Glowee brand is operated by BioDotDotDot Pty Ltd in Australia, while a prior French entity, GLOWEE SAS, underwent insolvency proceedings in 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glowee.